Candel Therapeutics, Inc.

Direct answer

Candel Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CADL.

Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical firm based in Needham, Massachusetts, dedicated to developing innovative immunotherapies for cancer patients. Its pipeline features CAN-2409, which is presently in Phase II clinical trials for pancreatic and lung cancers, and has progressed to Phase III for prostate cancer. This therapy also successfully completed Phase Ib/II trials for high-grade...

Can you invest in Candel Therapeutics, Inc.?

Yes. Candel Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CADL.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Candel Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.